Literature DB >> 6976961

In-vivo properties of SQ 26,776.

D P Bonner, R R Whitney, C O Baughn, B H Miller, S J Olsen, R B Sykes.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6976961     DOI： 10.1093/jac/8.suppl_e.123

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Treatment of uncomplicated gonorrhoea with single dose aztreonam.

Authors:  D T Evans; A J Crooks; C Jones; R A Holman; S W Price
Journal:  Genitourin Med       Date:  1986-10

2.  In vivo evaluation of tigemonam, a novel oral monobactam.

Authors:  J M Clark; S J Olsen; D S Weinberg; M Dalvi; R R Whitney; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Evaluation of aztreonam in the treatment of severe bacterial infections.

Authors:  J Romero-Vivas; M Rodríguez-Créixems; E Bouza; T Hellín; A Guerrero; J Martínez-Beltrán; M García de la Torre
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 4.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

5.  Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.

Authors:  W M Scheld; J P Brodeur; J C Gratz; P Foresman; G Rodeheaver
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  Prediction of aztreonam pharmacokinetics in humans based on data from animals.

Authors:  E A Swabb; D P Bonner
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

7.  High-pressure liquid chromatographic analysis of aztreonam in sera and urine.

Authors:  F G Pilkiewicz; B J Remsburg; S M Fisher; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

8.  Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.

Authors:  G Y Lavoie; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

9.  Mode of action of azthreonam.

Authors:  N H Georgopapadakou; S A Smith; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 10.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.